November 04, 2025

‘A Train Wreck’ of Whooping Cough Cases?

Louisiana’s delayed response to a severe whooping cough outbreak highlights concerns about vaccine communication and public health response.

KFF Health News

October 31, 2025

Single-Injection Omvoh Option Simplifies Ulcerative Colitis Care

The FDA approved Eli Lilly’s interleukin-23p19 antagonist Omvoh (mirikizumab-mrkz) as a once-monthly single-injection maintenance option for adults with moderately to severely active ulcerative colitis.

Conexiant

October 30, 2025

Medical Oddities: The T Cell's Midlife Crisis

From immune midlife makeovers to minty myths, toxic tea, hopeful scrolls, and tearless onions—science got surprisingly human this week.

Conexiant

October 30, 2025

Viral Infections Increase Cardiovascular Disease Risk 

Systematic review identifies influenza, COVID-19, HIV, hepatitis C, and herpes zoster as significant cardiac risk factors in analysis of 155 studies.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

July 14, 2025

Potential Links Between Infection and Alzheimer’s Disease

Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant